Horii Ikuo | Biochemical Toxicology School Of Pharmaceutical Sciences Showa University
スポンサーリンク
概要
関連著者
-
Horii Ikuo
Worldwide Safety Sciences Pgrd Nagoya Laboratories Pfizer Inc.
-
Horii Ikuo
Biochemical Toxicology School Of Pharmaceutical Sciences Showa University
-
Horii I
Drug Safety Research And Development Pfizer Global Research And Development Nagoya Laboratories. Pfi
-
Horii Ikuo
Worldwide Safety Sciences Pfizer Global Research & Development Nagoya Laboratories Pfizer Inc.
-
Horii Ikuo
Showa Univ. (department Of Biochemical Toxicology School Of Pharmaceutical Sciences)
-
Horii Ikuo
Pfizer Global Research & Development Nagoya Laboratories Pfizer Inc.
-
Yamada Hiroshi
Drug Safety Research & Development Pfizer Global Research & Development Nagoya Laboratories
-
Horii Ikuo
Worldwide Safety Sciences
-
HORII Ikuo
Worldwide Safety Sciences, Nagoya Laboratories, Pfizer Global Research and Development, Pfizer Japan
-
Yamada Hiroshi
Worldwide Safety Sciences Pfizer Global Research And Development Nagoya Laboratories Pfizer Japan In
-
Yamada Hiroshi
worldwide safety sciences
-
Yamamoto Toshinori
Drug Safety Research & Development Pfizer Global Research & Development Nagoya Laboratories
-
Yamamoto T
Showa Univ. Tokyo Jpn
-
Yamamoto Toshinori
Department Of Biochemical Toxicology School Of Pharmaceutical Sciences Showa University
-
Kikkawa Rie
Worldwide Safety Sciences Pfizer Global Research And Development Nagoya Laboratories Pfizer Inc.
-
Kikkawa Rie
Worldwide Safety Sciences Global Research & Development Nagoya Laboratories Pfizer Inc.
-
Kikkawa Rie
Pfizer Global Research & Development Toxicology Nagoya Laboratoreis
-
Yamamoto Toshinori
Departments Of Clinical Pharmacy And Pharmacognosy School Of Pharmaceutical Sciences Showa Universit
-
Hamada Y.
Drug Safety Research And Development Pfizer Global Research And Development Nagoya Laboratories. Pfi
-
Yamamoto Toshinori
Department Of Pharmacology Medical College Of Oita
-
KIKKAWA Rie
Worldwide Safety Sciences, Pfizer Global Research & Development, Nagoya Laboratories, Pfizer Inc.
-
HAMADA Yoshimasa
Worldwide Safety Sciences, Pfizer Global Research and Development, Nagoya Laboratories, Pfizer Inc.
-
Fukushima Tamio
Drug Safety Research And Development Nagoya Laboratories Pfizer Japan Inc.
-
Fukushima Tamio
Pfizer Global Research & Development Toxicology Nagoya Laboratoreis
-
Hamada Yoshimasa
Worldwide Safety Sciences Global Research & Development Nagoya Laboratories Pfizer Japan Inc.
-
Fukushima Tamio
Biochemical Toxicology School Of Pharmaceutical Sciences Showa University
-
Hamada Yoshimasa
Worldwide Safety Sciences Global Research & Development Nagoya Laboratories Pfizer Inc.
-
YAMAMOTO Toshinori
Worldwide Safety Sciences, Pfizer Global Research & Development, Nagoya Laboratories, Pfizer Inc.
-
FUKUSHIMA Tamio
Worldwide Safety Sciences, Global Research & Development, Nagoya Laboratories, Pfizer Inc.
-
Fukushima Tamio
Worldwide Safety Sciences Pfizer Global Research & Development Nagoya Laboratories Pfizer Inc.
-
Fujikawa Masaaki
Drug Safety Research & Development Pfizer Global Research & Development Nagoya Laboratories
-
Fujikawa Masaaki
Worldwide Safety Sciences Pfizer Global Research & Development Nagoya Laboratories Pfizer Japan
-
Fujikawa Masaaki
Worldwide Safety Sciences Pfizer Global Research & Development Nagoya Laboratories Pfizer Japan
-
Fujikawa Masaaki
worldwide safety sciences
-
Abe Junko
Worldwide Safety Sciences Pfizer Global Research And Development Nagoya Laboratories Pfizer Japan In
-
Harada Takuma
Worldwide Safety Sciences Pfizer Global Research And Development Nagoya Laboratories Pfizer Japan In
-
Harada Takuma
Worldwide Safety Sciences Global Research & Development Nagoya Laboratories Pfizer Japan Inc.
-
Shiotani Motohiro
Worldwide Safety Sciences Pfizer Global Research And Development Nagoya Laboratories Pfizer Japan In
-
Abe Junko
Worldwide Safety Sciences Global Research & Development Nagoya Laboratories Pfizer Japan Inc.
-
Shitoni Motohiro
Worldwide Safety Sciences Global Research & Development Nagoya Laboratories Pfizer Japan Inc.
-
Shirai Maki
Worldwide Safety Sciences Pgrd Nagoya Laboratories Pfizer Inc.
-
HORII IKUO
Drug Safety Evaluation, Nagoya Laboratories, Pfizer Global Research and Development
-
Shirai Maki
Worldwide Safety Sciences Global Research & Development Nagoya Laboratories Pfizer Inc.
-
Mori C
Department Of Bioenvironmental Medicine Graduate School Of Medicine Chiba University
-
Mori Chisato
Department Of Bioenvironmental Medicine Graduate School Of Medicine Chiba University
-
Mori Chisato
千葉大学 医学研究院環境生命医学
-
SHIOTANI Motohiro
Worldwide Safety Sciences, Pfizer Global Research and Development, Nagoya Laboratories, Pfizer Japan
-
HARADA Takuma
Worldwide Safety Sciences, Pfizer Global Research and Development, Nagoya Laboratories, Pfizer Japan
-
ABE Junko
Worldwide Safety Sciences, Pfizer Global Research and Development, Nagoya Laboratories, Pfizer Japan
-
Mori Chisato
Department Of Anatomy Faculty Of Medicine Kyoto University
-
Moria Chisato
Department Of Bioenvironmental Medicine:environmental Health Science Project For Future Generations
-
Mori Chisato
Department Of Anatomy And Developmental Biology
-
Kurata Masaaki
ファイザー製薬中央研究所 安全性研究統括部
-
Tomizawa Kaori
Drug Safety Research & Development Pfizer Global Research & Development Nagoya Laboratories
-
Yamasaki Naoko
Worldwide Safety Sciences Pfizer Global Research & Development Nagoya Laboratories Pfizer Inc.
-
Horii Ikuo
Drug Safety Evaluation Pfizer Global Research And Development
-
Shiotani Motohiro
Worldwide Safety Sciences Global Research & Development Nagoya Laboratories Pfizer Inc.
-
Horii Ikuo
Drug Safety Evaluation Global Research & Development Pfizer Inc.
-
Kurata Masaaki
Drug Safety Research And Development Nagoya Laboratories Pfizer Global Research And Development Pfiz
-
HORII Ikuo
Pfizer Global Research & Development, Nagoya Laboratories, Pfizer Inc.
-
HAMADA Yoshimasa
Drug Safety Research and Development, Nagoya Laboratories, Pfizer Japan Inc.
-
KOMIYAMA Masatoshi
Department of Bioenvironmental Medline, Chiba Univ.
-
IDEGAMI Keiichi
Worldwide Safety Sciences, Pfizer Global Research & Development, Nagoya Laboratories, Pfizer Inc.
-
Idegami Keiichi
Worldwide Safety Sciences Global Research & Development Nagoya Laboratories Pfizer Japan Inc.
-
Komiyama M
Department Of Bioenvironmental Medicine Graduate School Of Medicine Chiba University
-
Komiyama Masatoshi
Department Of Anatomy And Cell Biology School Of Medicine Chiba Unversity
-
YAMASAKI Naoko
Worldwide Safety Sciences, Pfizer Global Research & Development, Nagoya Laboratories, Pfizer Inc.
-
KITAZAWA Ikue
Worldwide Safety Sciences, Pfizer Global Research and Development, Nagoya Laboratories, Pfizer Inc.
-
HORII IKUO
Toxicology, Worldwide Safety Sciences, Global Research & Development, Nagoya Laboratories, Pfizer In
-
Sasayama Yukiko
Worldwide Safety Sciences Pfizer Global Research & Development Nagoya Laboratories Pfizer Inc.
-
Hamada Yoshimasa
Drug Safety Research And Development Nagoya Laboratories Pfizer Japan Inc.
-
Zhou Yu
worldwide safety sciences
-
Kobayashi Kazuko
Research Compliance & Quality Assurance Coordination Department Research Division Chugai Pharmac
-
SHINDOH Hidetoshi
Pre-clinical Research Department
-
KAWASHIMA Akira
Safety Assessment Department
-
SHISHIDO Nobuyuki
Safety Assessment Department
-
NAKANO Kounosuke
Pre-clinical Research Department
-
FUKUSHIMA Tamio
Drug Safety Research and Development, Nagoya Laboratories, Pfizer Japan Inc.
-
YAMADA Hiroshi
Drug Safety Research and Development, Nagoya Laboratories, Pfizer Japan Inc.
-
TOMIZAWA Kaori
Worldwide Safety Sciences
-
HASHIMOTO Keitaro
Department of Pharmacology, Interdisciplinary Graduate School of Medicine and Engineering, Universit
-
Idegami Keiichi
Worldwide Safety Sciences Pfizer Global Research & Development Nagoya Laboratories Pfizer Inc.
-
Komiyama Masatoshi
Department Of Bioenvironmental Medicine:center For Environment Health And Field Sciences Chiba Unive
-
Kurata Masaaki
Worldwide Safety Sciences Pfizer Global Research And Development Nagoya Laboratories Pfizer Inc.
-
Yoshida Tomoko
Department Of Nuclear Engineering Nagoya University
-
Yoshida Takemi
Dept.biochem.toxicol. Showa Univ.
-
Yoshida T
Department Of Biochemical Toxicology School Of Pharmaceutical Science Showa University
-
Yoshida T
Department Of Biochemical Toxicology School Of Pharmaceutical Sciences Showa University
-
Yoshida Teiji
Department Of Physics Faculty Of Science Tohoku University
-
SASAYAMA Yukiko
Worldwide Safety Sciences, Pfizer Global Research & Development, Nagoya Laboratories, Pfizer Inc.
-
MAKO Tomomi
Worldwide Safety Sciences, Global Research & Development Nagoya Laboratories, Pfizer Japan Inc.
-
HAMADA YOSHIMASA
Toxicology, Worldwide Safety Sciences, Global Research & Development, Nagoya Laboratories, Pfizer In
-
TAKIZAWA Setsuko
Dept. of Preclinical Science, Nippon Roche Research Center
-
Kitazawa Ikue
Worldwide Safety Sciences Pfizer Global Research And Development Nagoya Laboratories Pfizer Inc.
-
Mako Tomomi
Worldwide Safety Sciences Global Research & Development Nagoya Laboratories Pfizer Japan Inc.
-
Yoshida Takahiko
Department Of Environmental Health Division Of Community And Environmental Health Tokai University S
-
Yoshida Takemi
School Of Pharmaceutical Sciences Showa University
-
Komiyama Masatoshi
Department Of Bioenvironmental Medicine
-
Hashimoto Keitaro
Department Of Pharmacology Interdisciplinary Graduate School Of Medicine And Engineering University
-
Takizawa Setsuko
Dept. Of Preclinical Science Nippon Roche Research Center
-
Hamada Yoshimasa
Toxicology Laboratory Mochida Pharmaceutical Co. Ltd.
-
Nakano Kohnosuke
Pre-clinical Research Department Research Division Chugai Pharmaceutical Co. Ltd.
-
Nakano Kounosuke
Pre-clinical Research Department Research Division Chugai Pharmaceutical Co. Ltd. Fuji Gotemba Resea
-
Shishido Nobuyuki
Safety Assessment Department Research Division Chugai Pharmaceutical Co. Ltd.
-
Shishido Nobuyuki
Safety Assessment Department Research Division Chugai Pharmaceutical Co. Ltd. Fuji Gotemba Research
-
Shindoh Hidetoshi
Department Of Toxicology And Pathology Department Of Pharmacokinetics And Metabolism Nippon Roche Re
-
Hashimoto Keitaro
Department Of Pharmacology Interdisciplinary Graduate School Of Medicine And Engineering University
-
Hashimoto Keitaro
Department Of Pharmacology Interdisciplinary Graduate School Of Medicine And Engineering University
-
Kobayashi Kazuko
Research Compliance & Quality Assurance Coordination Department Research Division Chugai Pharmac
-
Takizawa Setsuko
日本ロシュ
-
Kawashima Akira
Department Of Toxicology And Pathology Department Of Pharmacokinetics And Metabolism Nippon Roche Re
-
Yoshida Takemi
Pfizer Japan Inc. Drug Safety R&d Pfizer Global R&d
-
Taki Kenji
Biochemical Toxicology School Of Pharmaceutical Sciences Showa University
-
Ise Ryota
Biochemical Toxicology School Of Pharmaceutical Sciences Showa University
-
Sato Yasushi
Drug Safety Research & Development Pfizer Global Research & Development Nagoya Laboratories
-
Shindoh Hidetoshi
Pre-clinical Res. Dep. Res. Div. Chugai Pharmaceutical Co. Ltd. Kamakura Res. Labs.
-
SUZUKI Koji
Department of Public Health, Fujita Health University School of Health Sciences
-
IIDAKA Takeshi
Worldwide Safety Sciences, Nagoya Laboratories, Pfizer Global Research and Development, Pfizer Japan
-
IIDAKA TAKESHI
Drug Safety Evaluation, Nagoya Laboratories, Pfizer Global Research and Development
-
Iidaka Takeshi
ファイザー 中央研究所
-
Iidaka Takeshi
Drug Safety Research And Development Pfizer Global Research And Development Nagoya Laboratories. Pfi
-
Iidaka Takeshi
ファイザー製薬中央研究所 安全性研究統括部
-
Iidaka Takeshi
Drug Safety Research And Development Nagoya Laboratories Pfizer Global Research And Development Pfiz
-
Iidaka Takeshi
ファイザー製薬中央研究所 安全性研究
-
Iidaka Takeshi
Worldwide Safety Sciences Pgrd Nagoya Laboratories Pfizer Inc.
-
Aoyama Hideyuki
Pharmacutical Sciences Global Research And Development Nagoya Laboratories Pfizer Inc.
-
Sakimura Masanori
worldwide safety sciences
-
HORII Ikuo
Dept. of Preclinical Science, Nippon Roche Research Center
-
Horii Ikuo
Dept. Of Preclinical Science Nippon Roche Research Center
-
TOMIZAWA Kaori
Drug Safety Research & Development, Pfizer Global Research & Development, Nagoya Laboratories
-
FUJIKAWA Masaaki
Drug Safety Research & Development, Pfizer Global Research & Development, Nagoya Laboratories
-
SATO Yasushi
Drug Safety Research & Development, Pfizer Global Research & Development, Nagoya Laboratories
-
KIKKAWA Rie
Drug Safety Research & Development, Nagoya Laboratories, Pfizer Japan Inc.
-
SUGANO Kiyohiko
Worldwide Pharmaceutical Sciences, Pfizer Global Research & Development, Nagoya Laboratories, Pfizer
-
Sato Yasushi
Worldwide Safety Sciences, PGRD Nagoya Laboratories, Pfizer Inc.
-
Shiotani Motohiro
Safety Sciences, Nagoya Lab, Pfizer Japan Inc
-
Harada Takuma
Safety Sciences, Nagoya Lab, Pfizer Japan Inc
-
Abe Junko
Safety Sciences, Nagoya Lab, Pfizer Japan Inc
-
Hamada Yoshimasa
Safety Sciences, Nagoya Lab, Pfizer Japan Inc
-
Horii Ikuo
Safety Sciences, Nagoya Lab, Pfizer Japan Inc
-
SAWADA Yasufusa
Pharmacokinetics Dynamics Metabolism, Pfizer Global Research and Development, Nagoya Laboratories, P
-
Sakai Takanori
World wide safety sciences
-
Iwasaki Kazuhide
Pharmacokinetics Dynamics Metabolism Pfizer Japan Inc
-
KUNIHARA Mineo
Worldwide Safety Sciences, Pfizer Global Research & Development, Nagoya Laboratories, Pfizer Inc.
-
Sakimura Masanori
Worldwide Safety Sciences Pfizer Global Research & Development Nagoya Laboratories Pfizer Inc.
-
Kunihara Mineo
Worldwide Safety Sciences Pfizer Global Research & Development Nagoya Laboratories Pfizer Inc.
-
KURATA Masaaki
Toxicology Laboratory, Chugai Pharmaceutical Co., Ltd.
-
Horii Ikuo
Department Of Preclinical Science Nippon Roche K. K. Research Center
-
Katoh C
Nippon Roche K. K. Kanagawa Jpn
-
Katoh Chiaki
Dept.toxicology And Pathology Nippon Roche Research Center
-
Kurata Masaaki
Drug Safety Research And Development Nagoya Laboratories Pfizer Global Research And Development Pfiz
-
Kurata Masaaki
Toxicology Laboratory Chugai Pharmaceutical Co.
-
Adachi T
Department Of Genomic Drug Discovery Science Graduate School Of Pharmaceutical Sciences Kyoto Univer
-
Zhou Yu
Woldwide Safety Sciences, Nagoya Laboratories, Pfizer Inc.
-
Shirai Maki
Woldwide Safety Sciences, Nagoya Laboratories, Pfizer Inc.
-
Yamada Hiroshi
Woldwide Safety Sciences, Nagoya Laboratories, Pfizer Inc.
-
Horii Ikuo
Woldwide Safety Sciences, Nagoya Laboratories, Pfizer Inc.
-
Adachi T
Laboratory Of Metabolism Kyoto University Graduate School Of Human And Environmental Studies
-
Yoshida Takemi
Department Of Biochemical Toxicology School Of Pharmaceutical Science Showa University
-
KATO MASASHI
Worldwide Safety Sciences, Global Research & Development, Nagoya Laboratories, Pfizer Inc.
-
HORIMOTO MASAO
Worldwide Safety Sciences, Global Research & Development, Nagoya Laboratories, Pfizer Inc.
-
ADACHI TETSUYA
Research Institute for Advanced Science and Technology, Osaka Prefecture University
-
SASAYAMA YUKIKO
Toxicology, Worldwide Safety Sciences, Global Research & Development, Nagoya Laboratories, Pfizer In
-
YAMASAKI NAOKO
Toxicology, Worldwide Safety Sciences, Global Research & Development, Nagoya Laboratories, Pfizer In
-
KITAZAWA IKUE
Toxicology, Worldwide Safety Sciences, Global Research & Development, Nagoya Laboratories, Pfizer In
-
SHIOTANI Motohiro
Toxicology, Worldwide Safety Sciences, Global Research & Development, Pfizer Japan Inc.
-
HARADA Takuma
Toxicology, Worldwide Safety Sciences, Global Research & Development, Pfizer Japan Inc.
-
ABE Junko
Toxicology, Worldwide Safety Sciences, Global Research & Development, Pfizer Japan Inc.
-
FUJII Toshiyuki
Toxicology Research Laboratories, Fujisawa Pharmaceutical Co., Ltd.
-
Mako Tomomi
Worldwide Safety Sciences Pfizer Global Research & Development Nagoya Laboratories Pfizer Inc.
-
Yamamoto Toshinori
Investigative Toxicology & Pathology, Safety Sciences, Pfizer Global Research and Development, Nagoy
-
Kiba Akie
Investigative Toxicology & Pathology, Safety Sciences, Pfizer Global Research and Development, Nagoy
-
Yamada Hiroshi
Investigative Toxicology & Pathology, Safety Sciences, Pfizer Global Research and Development, Nagoy
-
Horii Ikuo
Investigative Toxicology & Pathology, Safety Sciences, Pfizer Global Research and Development, Nagoy
-
Suzuki Koji
Department Of Public Health Fujita Health University Of Health Sciences
-
Sugano Kiyohiko
Worldwide Pharmaceutical Sciences Pfizer Global Research & Development Nagoya Laboratories Pfize
-
Fujii T
Teikyo Univ. Tokyo Jpn
-
TAKIZAWA Setsuko
Toxicology and Pathology, Nippon Roche Research Center
-
FUKATSU Nobuko
Toxicology and Pathology, Nippon Roche Research Center
-
FUJII Toshiko
Pharmacology, Teikyo University, School of Medicine
-
Kiba Akie
Investigative Toxicology & Pathology Safety Sciences Pfizer Global Research And Development Nago
-
Kato M
Safety Study Department Nihon Bioresearch Inc.
-
Fukatsu Nobuko
Department Of Toxicology And Pathology Nippon Roche K. K. Research Center
-
Horimoto Masao
Worldwide Safety Sciences Global Research & Development Nagoya Laboratories Pfizer Inc.
-
Kato Masashi
Department Of Bioenvironmental Medicine Graduate School Of Medicine Chiba University
-
Katoh Chiaki
Dept. Of Preclinical Science Nippon Roche Research Center
-
Yamamoto Toshinori
Drug Metabolism Laboratory Chugai Pharmaceutical Co. Ltd.
-
Takizawa Setsuko
日本ロシュ研究所
-
TAKI KENJI
Departments of Emergency Medicine
-
Taki Kenji
Biochemical Toxicology, School of pharmaceutical sciences, Showa University
-
Ise Ryota
Biochemical Toxicology, School of pharmaceutical sciences, Showa University
-
TOMIZAWA KAORI
Pfizer WW Safety Sciences-Nagoya
-
YAMADA HIROSHI
Pfizer WW Safety Sciences-Nagoya
-
Horii Ikuo
Woldwide Safety Sciences Nagoya Laboratories Pfizer Inc.
-
Horii Ikuo
Biochemical Toxicology School Of Pharmaceutical Sciences Showa Univ.
-
Suzuki Koji
Department Of Applied Chemistry Faculty Of Science And Technology Keio University
-
Sawada Yasufusa
Pharmacokinetics Dynamics Metabolism Pfizer Global Research And Development Nagoya Laboratories Pfiz
-
Kato Masashi
Department Of Bioenvironmental Medline Chiba Univ.:center For Environment Health And Field Sciences
-
Suzuki Koji
Department Of Molecular Pathology Mei University School Of Medicine
-
Ise Ryota
Department Of Biochemical Toxicology School Of Pharmacy Showa University
著作論文
- Development of in vitro 3T3 Cell Neutral Red Uptake Phototoxicity Screening System(Test methods, Proceedings of the 32nd Annual Meeting)
- EFFECT OF DOSE REGIMEN ON THE TOXICITY OF 2'-DEOXY-2'-METHYLIDENECYTIDINE (DMDC) IN MONKEYS
- RELATIONSHIP BETWEEN AUC of 5'-DFUR AND TOXICITY OF CAPECITABINE, FLUOROPYRIMIDINE CARBAMATE ANALOGS, AND 5'-DFUR IN MONKEYS, MICE, AND RATS
- CHANGES OF MICRO-RNA EXPRESSION IN RAT LIVER TREATED BY ACETAMINOPHEN OR CARBON TETRACHLORIDE : REGULATING ROLE OF MICRO-RNA FOR RNA EXPRESSION
- EVALUATION OF HUMAN HEPATOCYTE CHIMERIC MICE AS A MODEL FOR TOXICOLOGICAL INVESTIGATION USING PANOMIC APPROACHES : EFFECT OF ACETAMINOPHEN ON THE EXPRESSION PROFILES OF PROTEINS AND ENDOGENOUS METABOLITES IN LIVER, PLASMA AND URINE
- GENOMIC CLUSTER AND NETWORK ANALYSIS FOR PREDICTIVE SCREENING FOR HEPATOTOXICITY
- PHYSICOCHEMICAL AND CELL-BASED APPROACH FOR EARLY SCREENING OF PHOSPHOLIPIDOSIS-INDUCING POTENTIAL
- INVESTIGATION OF PROTEOMIC BIOMARKERS IN IN VIVO HEPATOTOXICITY STUDY OF RAT LIVER : TOXICITY DIFFERENTIATION IN HEPATOTOXICANTS
- IN VIVO HEPATOTOXICITY STUDY OF RATS IN COMPARISON WITH IN VITRO HEPATOTOXICITY SCREENING SYSTEM
- Introduction of the in vivo Mini-tox study as an effective tool to improve confidence in safety in the early stage of drug development (2) Effects of atypical antipsychotics X(Test methods, Proceedings of the 32nd Annual Meeting)
- Investigation of protein expression induced by hepatotoxicants in rat hepatocytes cultures and livers(Proceedings of the 32nd Annual Meeting)
- Changes of sperm functions and epididymal gene expression in the rats treated with sulfasalazine for several days(Development, Reproduction, Proceedings of the 32nd Annual Meeting)
- Effect of aging on QT interval in guinea pigs(Circulatory system, Proceedings of the 32nd Annual Meeting)
- Comparison between in vitro- and in vivo-hepatotoxicity for the investigation of a hepatotoxicity screening system in primary cell cultures(Liver, Alimentary system, Proceedings of the 32nd Annual Meeting)
- PRACTICAL APPLICATION OF GUINEA PIG TELEMETRY SYSTEM FOR QT EVALUATION
- EFFECT OF AUTONOMIC NERVOUS FUNCTION ON QT INTERVAL IN DOGS
- IDENTIFICATION OF OXIDATIVE STRESS-RELATED PROTEINS FOR PREDICTIVE SCREENING OF HEPATOTOXICITY USING A PROTEOMIC APPROACH
- EFFECTS OF MALE REPRODUCTIVE TOXICANTS ON GENE EXPRESSION IN RAT TESTES
- PROTEIN EXPRESSION ANALYSIS OF RAT TESTES INDUCED TESTICULAR TOXICITY WITH SEVERAL REPRODUCTIVE TOXICANTS
- INVESTIGATION OF A HEPATOTOXICITY SCREENING SYSTEM IN PRIMARY CELL CULTURES : WHAT BIOMARKERS WOULD NEED TO BE ADDRESSED TO ESTIMATE TOXICITY IN CONVENTIONAL AND NEW APPROACHES?
- P8-45 Estimation of exposure in toxicology study in discovery stage(BLOOD/TOXICOKINETICS/OTHERS-2)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)
- P8-34 Usefulness of beam walking test for prediction of adverse effects, "vertigo and dizziness"(STATISTICAL AND TEST METHODS/LOCAL STIMURATION)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)
- In Vitro Method Investigation for Drugs Induced Vasculitis Evaluation (CIRCULATORY SYSTEM) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
- P7-24 Investigation of the hepato-toxicity screening system in primary cell culture(IMMUNE AND ALLERGIC SYSTEM/KIDNEYS AND URINARY EXCRETION SYSTEM/CYTOTOXICITY/OTHERS-1)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)
- P6-46 Effect of reproductive toxicants on the protein expression in the rat testis(TOXICOGENOMICS)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)
- P6-45 Effect of reproductive toxicants on the gene expression in the testes of rats(TOXICOGENOMICS)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)
- Effects of sulfasalazine on gene expressions in testis and epididymis (TOXICOGENOMICS AND TOXICOPROTEOMICS) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
- SIMULTANEOUS MEASUREMENT OF NUCLEATED CELL COUNTS AND CELLULAR DIFFERENTIALS IN RAT BONE MARROW EXAMINATION USING FLOW CYTOMETER
- P7-45 Usefulness of fecal occult blood kits by the immunity method : Examination in rats and dogs(GENERAL TOXICITY)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)
- MECHANISM FOR SHORTENING PT AND APTT IN DOGS AND RATS : EFFECT OF FIBRINOGEN ON PT AND APTT
- Measurements for rat and canine D-dimer in plasma using human clinical latex agglutination reagents (BLOOD SYSTEM) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
- Mechanism for shortened PT and APTT in dogs and rats-Effect of fibrinogen on PT and APTT- (BLOOD SYSTEM) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
- P7-61 Variation of neurotransmitter contents in the cerebrospinal fluid of conscious dogs(ENDOCRINE AND NERVOUS SYSTEM)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)
- P7-58 Comparison of the chemicals on open-field activities in rats(ENDOCRINE AND NERVOUS SYSTEM)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)
- Evaluation of QT interval with telemetry system in conscious guinea pigs (CIRCULATORY SYSTEM) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
- P6-14 Development of telemetry system for QT evaluation in guinea pigs(LIVER AND DIGESTIVE SYSTEM/CIRCULATORY SYSTEM-1/DEVELOPMENT AND REPRODUCTION)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)
- 2A-03 Flow cytometric analysis for sperm viability and counts in rats treated with Trimethylphosphate or Pyridoxine
- Toxicomarker Discovery for Hepatotoxicity using Proteome Analysis Technology (TOXICOGENOMICS AND TOXICOPROTEOMICS) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
- Usefulness of Teflon sonde for oral administration in rats (TEST METHODS) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
- Effect of Etretinate(Aromatic retinoid) treatment during gestation and lactation periods on viability and somatic growth in Fl rats
- P8-33 Validation of an in vitro screening assay for phospholipidosis in drug development(STATISTICAL AND TEST METHODS/LOCAL STIMURATION)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)
- The use of gene expression profiling in rat hepatocyte cultures using adapter-tagged competitive PCR (TOXICOGENOMICS AND TOXICOPROTEOMICS) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
- MicroRNAs expression in the Ethylene Glycol Monomethyl Ether-induced testicular lesion
- 6-Mercaptopurine-induced histopathological changes and xanthine oxidase expression in rat placenta